Tekla Healthcare Investors (HQH) Peer Comparison
$21.65
$0.33
(1.55%)
As on 17-Sep-2026 13:30EDT
Market cap
$1,286 Mln
Revenue (TTM)
$19 Mln
P/E Ratio
5
P/B Ratio
1.1
Div. Yield
10.1 %
Edit
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1,286 | 3,286 | 2,474 | 2,089 | 1,857 |
Revenue ($ Mln) |
100 | 948 | 185 | 266 | 205 |
Net Profit ($ Mln) |
98.61 | -375.00 | 490.57 | 314.36 | 254.31 |
Net Margin (%) |
1,694.62 | -39.56 | 264.61 | -- | -- |
RoE (%) |
9.16 | -6.75 | 19.67 | 20.33 | 13.09 |
Price to Earnings |
5.00 | -- | 5.06 | 6.56 | 5.47 |
Price-To-Book |
1.12 | 0.65 | 0.94 | 1.22 | 0.92 |
Income Statement ($ Mln)
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
99.81 | 1,171.00 | -42.18 | 265.96 | 204.61 |
|
Cost of Revenue
|
-- | 356.00 | 23.80 | 20.58 | 8.19 |
|
Gross Profit
|
99.81 | 815.00 | -65.98 | 245.38 | 196.42 |
|
Operating Expenses
|
1.20 | 235.00 | 8.57 | -69.41 | -57.89 |
|
Operating Profit (EBIT)
|
98.61 | 580.00 | -74.55 | 314.79 | 254.31 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
98.61 | 23.00 | -74.55 | 314.36 | 254.31 |
|
Provision for Tax
|
-- | 12.00 | -27.69 | -- | -- |
|
Profit after Tax (Net Income)
|
98.61 | 11.00 | -46.87 | 314.36 | 254.31 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 11.00 | -- | -- | -- |
Liabilities ($ Mln)
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,093.83 | 5,849.00 | 2,332.26 | 1,717.10 | 1,982.80 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
2.22 | 7,880.00 | 880.06 | 18.50 | 2.44 |
|
Current Liabilities
|
1.21 | -- | 10.54 | 17.50 | 2.04 |
|
Total Liabilities
|
1,097.26 | 13,729.00 | 3,222.86 | 1,753.11 | 1,985.24 |
Assets ($ Mln)
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,094.64 | 13,548.00 | 3,222.04 | 1,721.20 | 1,972.27 |
|
Current Assets
|
2.61 | 181.00 | 0.82 | 31.91 | 12.97 |
|
Total Assets
|
1,097.26 | 13,729.00 | 3,222.86 | 1,753.11 | 1,985.24 |
|
Total Debt*
|
-- | 7,634.00 | 414.96 | 17.50 | -- |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-- | 592.00 | 223.53 | -47.75 | -- |
|
Cash Flow from Investing Activities
|
-- | 236.00 | -- | 324.34 | -- |
|
Cash from Financing Activities
|
-- | -679.00 | -223.53 | -256.13 | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
9.16 | 0.08 | -1.58 | 20.17 | 13.09 |
|
ROE (%)
|
9.16 | 0.18 | -1.92 | 20.33 | 13.09 |
|
ROA (%)
|
9.14 | 0.08 | -1.38 | 18.21 | 13.07 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
98.80 | 0.94 | 111.12 | 118.20 | 124.29 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
8.27 | 0.05 | -1.03 | -0.03 | -0.36 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-46.68 | -98.12 | -105.04 | 15.45 | -20.71 |
|
EPS Growth (%)
|
-0.48 | -0.98 | -- | -0.42 | -0.21 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
10.26 | 377.07 | -- | 4.94 | 6.87 |
|
Price / Book Value
|
0.92 | 0.71 | -- | 0.91 | 0.88 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
10.26 | 17.44 | -5.57 | 4.90 | 6.87 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 1.31 | 0.18 | 0.01 | -- |
|
Short term debt to equity ratio
|
-- | 0.00 | -- | 0.01 | -- |
|
Current Ratio
|
2.15 | -- | 0.08 | 1.82 | 6.37 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
-- | 1.05 | -- | -- | -- |
Operating Efficiency Ratios
| Tekla Healthcare Investors (HQH) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
2.54 | 35.10 | -1.95 | 0.59 | 6.25 |
|
Asset Turnover
|
0.09 | 0.08 | -0.01 | 0.15 | 0.11 |
|
Receivable days
|
5.55 | 122.27 | -27.00 | 1.18 | 21.00 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
-- | 100.03 | -- | 249.67 | 102.43 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
